Hypersensitivity  >>  roflumilast  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
roflumilast / Generic mfg.
NCT01365533: A Study to Evaluate the Effect of Roflumilast on Airway Inflammation and Function Following Allergen Challenge in Subjects With Allergic Asthma

Completed
2
48
Canada
Roflumilast, Placebo
AstraZeneca
Allergic Asthma
07/05
07/05
NCT01765192 / 2012-002064-27: Roflumilast Plus Montelukast in Adults With Severe Asthma

Completed
2
64
Europe, RoW
Roflumilast, Daxas, Daliresp, Roflumilast placebo, Montelukast, Singulair, Pluralair
AstraZeneca
Asthma
10/13
10/13
NCT01862029: Effects of Roflumilast on Insulin and Blood Sugar Levels in Prediabetic Overweight and Obese Individuals

Completed
1/2
24
US
Roflumilast
National Heart, Lung, and Blood Institute (NHLBI)
Obesity
07/17
07/17

Download Options